In particular, when pathological puncture biopsy samples have relatively few tumor cells and diffuse distribution and are negative for ER, PR, and HER-2, they are more likely to be confused with triple-negative breast cancer. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.